1.
Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Colston E, Hippeli L, Napoli A, Kisa RM, Banerjee S, Menter A, Thaçi D, Blauvelt A. Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2023Mar.13 [cited 2024Oct.26];7(2):s118. Available from: https://skin.dermsquared.com/skin/article/view/1968